ASTEC LIFESCIENCES LIMITED

Astec Lifesciences Limited successfully conducted its 32nd Annual General Meeting (AGM) on July 31, 2026, via Video Conferencing. The meeting, held in compliance with MCA and SEBI regulations, saw the adoption of the Annual Report for the Financial Year 2025-26 and the approval of various resolutions. The company provided remote e-voting facilities and allowed e-voting during the meeting. The results of the voting will be declared within two working days. Key attendees included the Board of Directors, statutory auditors B S R & Co. LLP, and secretarial auditors BNP & Associates.

Astec Lifesciences Limited successfully conducted its 32nd Annual General Meeting (AGM) on July 31, 2026, via Video Conferencing. The meeting, held in compliance with MCA and SEBI regulations, saw the adoption of the Annual Report for the Financial Year 2025-26. Shareholders also voted on resolutions including the adoption of financial statements and the re-appointment of a director. The company provided remote e-voting facilities and allowed e-voting during the AGM. The proceedings included a welcome by the Company Secretary, a speech by the Chairperson, and attendance by directors and auditors.

Astec LifeSciences Limited announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported a consolidated total income of ₹84.3 crore, a decrease from ₹91.6 crore in the same period last year. However, Astec achieved EBITDA breakeven at ₹0.1 crore, a significant improvement from an EBITDA loss of ₹-10.5 crore in Q1 FY26. The net loss after tax narrowed to ₹-18.7 crore from ₹-33.0 crore year-on-year. Revenue from Enterprise Products grew by 41.6% to ₹51.8 crore, while revenue from Contract Manufacturing & New Products declined by 41.8% to ₹31.8 crore. The Chairperson attributed the EBITDA improvement to a favorable product mix, improved margins, and enhanced capacity utilization, despite the overall revenue dip.

Astec Lifesciences Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results as per Indian Accounting Standards (IND AS). The company also noted the Limited Review Reports from its Statutory Auditors, which carried an unmodified opinion on the financial results.

Astec Lifesciences Ltd announced the outcome of its Board Meeting held on July 31, 2026. The Board approved the Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2026, as per Indian Accounting Standards (IND AS). The company also noted the Limited Review Reports from its Statutory Auditors, which contained an unmodified opinion on these results. The meeting commenced at 2:00 p.m. and concluded at 3:05 p.m.

Astec Lifesciences Ltd has announced that its Board of Directors will convene on July 31, 2026. The primary agenda for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter ending June 30, 2026. This review will take place after the Audit Committee has examined the results. The company has also made the intimation available on its website, www.godrejastec.com.

Astec LifeSciences Limited has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26, which includes audited financial statements, Board of Directors' reports, and Statutory Auditors' reports. The Annual Report is available on the company's website. Shareholders will be able to access the report via a weblink provided in letters sent to them. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026.

Astec Lifesciences Ltd has announced the closure of its Register of Members and Share Transfer Books from July 26 to July 30, 2026, for its 32nd Annual General Meeting (AGM). The AGM is scheduled for July 31, 2026, to be held via Video Conferencing. The company has also made its Annual Report for FY 2025-26 available on its website and via a weblink sent to shareholders. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date, July 24, 2026.

Astec Lifesciences Ltd has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26, which includes audited financial statements and reports. The Annual Report is available on the company's website. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date, July 24, 2026.

Astec LifeSciences Limited has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26, which includes the audited financial statements and reports. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date of July 24, 2026.